According to the new market research report "Contrast Media Injectors Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Heads, Syringes), Accessories), Application (Radiology, Interventional Cardiology), & End Users (Hospitals) - Global Forecast to 2024", published by MarketsandMarkets™, the global Contrast Media Injectors Market is projected to reach USD 1.8 billion by 2024 from USD 1.3 billion in 2019, at a CAGR of 6.1% during the forecast period.
Browse in-depth TOC on "Contrast Media Injectors Market"
134 – Tables
28 – Figures
134 – Pages
Download PDF Brochure:
Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the Contrast Media Injectors Market. However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.
The consumables segment accounted for the largest share of the contrast media injection market, by type, in 2018.
Based on the product, the Contrast Media Injectors Market is segmented into injector systems, consumables, and accessories. The injector systems market is segmented further into CT injectors, MRI injectors, Angiography injectors. The consumables segment is segmented further into injector heads, syringes, tubes, other consumables. In 2018, the consumables segment accounted for the largest share of the Contrast Media Injectors Market. The large share of this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures. These consumables need to be re-purchased for every new procedure, as opposed to instruments, thus driving its demand.
The interventional cardiology segment to register the highest CAGR in the contrast media injector market during the forecast period.
Based on application, the Contrast Media Injectors Market is segmented into radiology, interventional radiology, and interventional cardiology. In 2018, the interventional cardiology segment had the highest growth rate of the Contrast Media Injectors Market. The rising prevalence of CVD is driving the growth of this application segment.
The hospital segment will continue to dominate the contrast media injector end-user market during the forecast period
Based on end-user, the Contrast Media Injectors Market is segmented into hospitals and diagnostic imaging centers. The hospital segment commanded the highest growth rate of the global Contrast Media Injectors Market in 2018. The high growth rate of this segment can be attributed to the rising number of diagnostic imaging procedures performed in hospitals and the growing inclination of hospitals towards the automation & digitization of radiology patient workflow. Additionally, increasing adoption of minimally invasive procedures (including diagnostic imaging systems) in hospitals to improve the quality of patient care, and rising adoption of advanced imaging modalities to improve workflow efficiency in hospitals are other key factors driving market growth.
Get 10% Customization on this Report:
North America will continue to dominate the contrast media injector market during the forecast period
Geographically, North America dominated the contrast media injector market in 2018, while Asia Pacific is expected to register the highest CAGR during the forecast period. The large share of North America is attributed to the increasing number of diagnostic imaging units & examinations, rising aging population & corresponding disease conditions in the US, significant focus & government investments in the medical imaging arena, and increasing research activities in Canada.
Major players operating in the Contrast Media Injector market include Bayer Ag (Germany), Bracco Imaging S.P.A (Italy), Guerbet Group (France), Ulrich GmbH & Co. KG (Germany), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical-Device Technology Co., Ltd. (Sinomdt) (China), APOLLO RT Co. Ltd. (Hongkong), Shenzhen Anke High-Tech Co. Ltd. (China), Shenzen Seacrown Electromechanical Co. Ltd. (China), and Medtron AG (Germany).
Browse Related Reports:
Contrast Media/Contrast Agents Market
by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022
Diagnostic Imaging Market by Product (MRI (Open, Closed), Ultrasound (2D, 3D/4D, Doppler), CT, X-Ray (Digital, Analog), SPECT, Hybrid PET, Mammography), Application (OB/Gyn, Cardiology, Oncology), End User (Hospitals, Imaging Centers) - Forecast to 2024
Contrast Media Injectors Market
US EVERY YEAR FOR THEIR
HOME ❯ TOP MARKET REPORTS ❯ CONTRAST MEDIA INJECTORS MARKET
Contrast Media Injectors Market By Product (Injector Systems (CT
Injector, MRI Injector), Consumables (Syringes), Accessories),
Application (Radiology, Interventional Cardiology), & End Users
(Hospitals) - Global Forecast to 2025
[163 Pages Report] The global contrast media injectors market size is estimated to be USD 1.3
billion in 2020 and projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4% between 2020
and 2025. Factors such as the growing prevalence of cancer and CVD; a large number of approvals
for contrast agents; and increasing investments, funds, and grants by government organizations
are driving the growth of the contrast media injectors market. However, the high cost of contrast
media injectors and consumables & accessories is restraining the growth of the market to a certain
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 impact on the Global Contrast Injectors Market
The Covid-19 pandemic has had a devastating global impact on the health of the population as well
as huge economic impact on most of the countries. The Pandemic has put a huge strain on the
healthcare systems around the world. During this period, health care institutions and providers have
been instructed to stop performing elective surgical procedures and medical examinations to slow
the spread of disease and conserve health care resources for COVID-19 patients. Many radiology
departments have experienced a rapid decline in imaging case volume. Radiology practices should
anticipate 50% to 70% decreases in imaging volume that will last a minimum of 3 to 4 months,
depending on the location of practice and the severity of the COVID-19 pandemic in each region.
While the future looks uncertain due to Covid-19. The demand for contrast i